Jiangsu Total Current Liabilities vs Non Current Liabilities Total Analysis

688399 Stock

72.66 2.46 3.50%

Jiangsu Bioperfectus financial indicator trend analysis is infinitely more than just investigating Jiangsu Bioperfectus recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Jiangsu Bioperfectus is a good investment. Please check the relationship between Jiangsu Bioperfectus Total Current Liabilities and its Non Current Liabilities Total accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Jiangsu Bioperfectus Technologies. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

Total Current Liabilities vs Non Current Liabilities Total

Total Current Liabilities vs Non Current Liabilities Total Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Jiangsu Bioperfectus Total Current Liabilities account and Non Current Liabilities Total. At this time, the significance of the direction appears to have almost identical trend.

The correlation between Jiangsu Bioperfectus' Total Current Liabilities and Non Current Liabilities Total is 0.91. Overlapping area represents the amount of variation of Total Current Liabilities that can explain the historical movement of Non Current Liabilities Total in the same time period over historical financial statements of Jiangsu Bioperfectus Technologies, assuming nothing else is changed. The correlation between historical values of Jiangsu Bioperfectus' Total Current Liabilities and Non Current Liabilities Total is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Total Current Liabilities of Jiangsu Bioperfectus Technologies are associated (or correlated) with its Non Current Liabilities Total. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Non Current Liabilities Total has no effect on the direction of Total Current Liabilities i.e., Jiangsu Bioperfectus' Total Current Liabilities and Non Current Liabilities Total go up and down completely randomly.

Correlation Coefficient

0.91

Relationship Direction	Positive
Relationship Strength	Very Strong

View All Relationships

Total Current Liabilities

Total Current Liabilities is an item on Jiangsu Bioperfectus balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Jiangsu Bioperfectus Technologies are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Non Current Liabilities Total

Most indicators from Jiangsu Bioperfectus' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Jiangsu Bioperfectus current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Jiangsu Bioperfectus Technologies. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

The current year's Tax Provision is expected to grow to about (1.8 M). In addition to that, Selling General Administrative is expected to decline to about 275.6 M

	2021	2022	2023	2024 (projected)
Gross Profit	2.0B	3.4B	257.7M	244.8M
Total Revenue	2.8B	5.5B	403.2M	383.0M

Gross Profit Total Revenue

Jiangsu Bioperfectus fundamental ratios Correlations

	Total Assets	Total Current Liabilities	Total Stockholder Equity	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Net Receivables	Non Current Liabilities Total	Inventory	Other Current Assets	Total Liab	Total Current Assets	Intangible Assets	Other Current Liab	Other Liab	Net Tangible Assets	Other Assets	Common Stock Shares Outstanding	Deferred Long Term Liab	Net Invested Capital	Net Working Capital	Common Stock	Property Plant Equipment	Capital Stock
Total Assets		0.93	1.0	0.93	0.84	0.98	0.93	0.05	0.89	0.99	0.9	-0.58	0.95	1.0	0.8	0.65	0.89	0.89	0.85	0.87	0.87	0.99	0.99	0.87	0.91	0.87
Total Current Liabilities	0.93		0.89	0.82	0.86	0.89	0.83	0.17	0.96	0.91	0.99	-0.53	1.0	0.94	0.72	0.86	0.76	0.76	0.7	0.73	0.74	0.89	0.89	0.73	0.81	0.72
Total Stockholder Equity	1.0	0.89		0.93	0.82	0.98	0.93	0.02	0.85	0.99	0.85	-0.58	0.91	0.99	0.8	0.59	0.9	0.91	0.87	0.89	0.88	1.0	1.0	0.89	0.92	0.88
Retained Earnings	0.93	0.82	0.93		0.78	0.92	0.99	-0.05	0.8	0.92	0.79	-0.52	0.85	0.92	0.72	0.42	0.98	0.98	0.97	0.83	0.98	0.95	0.94	0.83	0.97	0.84
Accounts Payable	0.84	0.86	0.82	0.78		0.77	0.72	0.0	0.96	0.85	0.81	-0.36	0.87	0.86	0.55	0.63	0.67	0.67	0.66	0.54	0.67	0.81	0.83	0.54	0.67	0.53
Cash	0.98	0.89	0.98	0.92	0.77		0.93	0.1	0.82	0.99	0.87	-0.61	0.92	0.98	0.82	0.6	0.91	0.89	0.86	0.89	0.87	0.98	0.98	0.89	0.91	0.88
Non Current Assets Total	0.93	0.83	0.93	0.99	0.72	0.93		0.03	0.78	0.92	0.81	-0.6	0.86	0.92	0.79	0.47	0.98	0.99	0.97	0.89	0.98	0.95	0.94	0.88	1.0	0.9
Non Currrent Assets Other	0.05	0.17	0.02	-0.05	0.0	0.1	0.03		0.11	0.07	0.18	-0.47	0.15	0.04	0.48	0.32	-0.03	-0.07	0.04	0.01	-0.09	0.02	-0.01	0.01	0.0	0.0
Net Receivables	0.89	0.96	0.85	0.8	0.96	0.82	0.78	0.11		0.88	0.93	-0.45	0.96	0.91	0.63	0.79	0.7	0.71	0.67	0.62	0.7	0.85	0.86	0.62	0.74	0.61
Non Current Liabilities Total	0.99	0.91	0.99	0.92	0.85	0.99	0.92	0.07	0.88		0.88	-0.6	0.94	1.0	0.82	0.63	0.9	0.89	0.85	0.88	0.86	0.99	0.99	0.88	0.9	0.87
Inventory	0.9	0.99	0.85	0.79	0.81	0.87	0.81	0.18	0.93	0.88		-0.51	0.99	0.91	0.69	0.88	0.73	0.72	0.66	0.71	0.71	0.85	0.85	0.71	0.79	0.7
Other Current Assets	-0.58	-0.53	-0.58	-0.52	-0.36	-0.61	-0.6	-0.47	-0.45	-0.6	-0.51		-0.55	-0.57	-0.83	-0.39	-0.59	-0.56	-0.56	-0.69	-0.48	-0.58	-0.58	-0.69	-0.58	-0.69
Total Liab	0.95	1.0	0.91	0.85	0.87	0.92	0.86	0.15	0.96	0.94	0.99	-0.55		0.96	0.74	0.83	0.79	0.79	0.73	0.76	0.77	0.91	0.91	0.76	0.84	0.76
Total Current Assets	1.0	0.94	0.99	0.92	0.86	0.98	0.92	0.04	0.91	1.0	0.91	-0.57	0.96		0.79	0.67	0.88	0.88	0.84	0.86	0.86	0.99	0.99	0.87	0.9	0.86
Intangible Assets	0.8	0.72	0.8	0.72	0.55	0.82	0.79	0.48	0.63	0.82	0.69	-0.83	0.74	0.79		0.52	0.78	0.75	0.74	0.87	0.66	0.8	0.79	0.87	0.77	0.86
Other Current Liab	0.65	0.86	0.59	0.42	0.63	0.6	0.47	0.32	0.79	0.63	0.88	-0.39	0.83	0.67	0.52		0.34	0.34	0.26	0.45	0.32	0.58	0.57	0.45	0.46	0.43
Other Liab	0.89	0.76	0.9	0.98	0.67	0.91	0.98	-0.03	0.7	0.9	0.73	-0.59	0.79	0.88	0.78	0.34		1.0	0.98	0.9	0.97	0.92	0.92	0.89	0.97	0.91
Net Tangible Assets	0.89	0.76	0.91	0.98	0.67	0.89	0.99	-0.07	0.71	0.89	0.72	-0.56	0.79	0.88	0.75	0.34	1.0		0.98	0.89	0.99	0.92	0.92	0.88	0.99	0.9
Other Assets	0.85	0.7	0.87	0.97	0.66	0.86	0.97	0.04	0.67	0.85	0.66	-0.56	0.73	0.84	0.74	0.26	0.98	0.98		0.81	0.98	0.88	0.88	0.8	0.95	0.83
Common Stock Shares Outstanding	0.87	0.73	0.89	0.83	0.54	0.89	0.89	0.01	0.62	0.88	0.71	-0.69	0.76	0.86	0.87	0.45	0.9	0.89	0.81		0.82	0.9	0.89	1.0	0.9	1.0
Deferred Long Term Liab	0.87	0.74	0.88	0.98	0.67	0.87	0.98	-0.09	0.7	0.86	0.71	-0.48	0.77	0.86	0.66	0.32	0.97	0.99	0.98	0.82		0.9	0.89	0.81	0.97	0.83
Net Invested Capital	0.99	0.89	1.0	0.95	0.81	0.98	0.95	0.02	0.85	0.99	0.85	-0.58	0.91	0.99	0.8	0.58	0.92	0.92	0.88	0.9	0.9		1.0	0.9	0.94	0.89
Net Working Capital	0.99	0.89	1.0	0.94	0.83	0.98	0.94	-0.01	0.86	0.99	0.85	-0.58	0.91	0.99	0.79	0.57	0.92	0.92	0.88	0.89	0.89	1.0		0.89	0.92	0.89
Common Stock	0.87	0.73	0.89	0.83	0.54	0.89	0.88	0.01	0.62	0.88	0.71	-0.69	0.76	0.87	0.87	0.45	0.89	0.88	0.8	1.0	0.81	0.9	0.89		0.89	1.0
Property Plant Equipment	0.91	0.81	0.92	0.97	0.67	0.91	1.0	0.0	0.74	0.9	0.79	-0.58	0.84	0.9	0.77	0.46	0.97	0.99	0.95	0.9	0.97	0.94	0.92	0.89		0.91
Capital Stock	0.87	0.72	0.88	0.84	0.53	0.88	0.9	0.0	0.61	0.87	0.7	-0.69	0.76	0.86	0.86	0.43	0.91	0.9	0.83	1.0	0.83	0.89	0.89	1.0	0.91

Click cells to compare fundamentals

Jiangsu Bioperfectus Account Relationship Matchups

Jiangsu Bioperfectus fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	1.2B	2.3B	3.5B	4.9B	3.9B	2.3B
Total Current Liabilities	94.2M	522.4M	855.6M	932.6M	363.9M	399.2M
Total Stockholder Equity	1.0B	1.7B	2.5B	3.8B	3.4B	1.8B
Retained Earnings	157.5M	801.2M	1.7B	2.9B	2.5B	2.6B
Accounts Payable	9.2M	79.2M	132.5M	433.1M	75.0M	103.1M
Cash	248.7M	1.1B	1.3B	1.8B	1.8B	891.4M
Non Current Assets Total	263.9M	497.8M	960.5M	1.2B	1.2B	1.3B
Non Currrent Assets Other	6.0M	11.7M	22.2M	2.7M	157.1K	149.2K
Net Receivables	39.7M	157.5M	342.6M	564.0M	108.7M	173.3M
Non Current Liabilities Total	39.3M	90.7M	107.3M	180.3M	137.4M	79.3M
Inventory	19.0M	162.9M	250.3M	236.3M	93.9M	111.3M
Other Current Assets	2.4M	14.3M	24.2M	49.3M	18.8M	31.0M
Total Liab	133.6M	613.2M	962.9M	1.1B	501.3M	478.5M
Total Current Assets	890.5M	1.8B	2.5B	3.7B	2.7B	1.7B
Intangible Assets	25.6M	26.6M	26.8M	27.4M	29.9M	23.0M
Other Current Liab	64.3M	197.3M	368.1M	242.1M	408.9K	388.5K
Other Liab	39.3M	90.7M	100.4M	169.7M	195.2M	205.0M
Net Tangible Assets	995.2M	1.6B	2.5B	3.8B	4.3B	4.5B
Other Assets	18.4M	52.4M	95.8M	168.6M	193.9M	203.6M
Deferred Long Term Liab	7.0M	25.6M	54.3M	74.2M	85.4M	89.6M
Net Invested Capital	1.0B	1.7B	2.7B	3.9B	3.6B	2.1B
Net Working Capital	796.2M	1.3B	1.7B	2.8B	2.3B	1.5B
Property Plant Equipment	219.9M	322.5M	715.0M	731.7M	841.5M	883.5M

Currently Active Assets on Macroaxis

TITAN	Titan Company Limited
U	Unity Software
PAYC	Paycom Soft
HBI	Hanesbrands
STLD	Steel Dynamics

Other Information on Investing in Jiangsu Stock

Balance Sheet is a snapshot of the financial position of Jiangsu Bioperfectus at a specified time, usually calculated after every quarter, six months, or one year. Jiangsu Bioperfectus Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Jiangsu Bioperfectus and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Jiangsu currently owns. An asset can also be divided into two categories, current and non-current.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Jiangsu Total Current Liabilities vs Non Current Liabilities Total Analysis

Total Current Liabilities vs Non Current Liabilities Total

Total Current Liabilities vs Non Current Liabilities Total Correlation Analysis

Correlation Coefficient

Total Current Liabilities

Non Current Liabilities Total

Jiangsu Bioperfectus fundamental ratios Correlations

Jiangsu Bioperfectus Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Jiangsu Bioperfectus fundamental ratios Accounts

Currently Active Assets on Macroaxis

Other Information on Investing in Jiangsu Stock

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Stockholder Equity	+ 1.0	Total Assets
Total Current Assets	+ 1.0	Total Assets
Total Liab	+ 1.0	Total Current Liabilities
Net Invested Capital	+ 1.0	Total Stockholder Equity
Net Working Capital	+ 1.0	Total Stockholder Equity
Property Plant Equipment	+ 1.0	Non Current Assets Total

Intangible Assets	- 0.83	Other Current Assets
Capital Stock	- 0.69	Other Current Assets
Common Stock	- 0.69	Other Current Assets
Common Stock Shares Outstanding	- 0.69	Other Current Assets
Other Current Assets	- 0.61	Cash
Other Current Assets	- 0.6	Non Current Liabilities Total